HER2 Positive Esophagogastric Cancer
1 clinical trials · Condition
◉ Watch HER2 Positive Esophagogastric Cancer
| Record | Firm | Date |
|---|---|---|
| Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer (NCT01769508) | SCRI Development Innovations, LLC | 2013-02-01 |
Track HER2 Positive Esophagogastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.